Optimizing Detection and Treatment of High-Risk Heart Failure Patients

RxRevu was awarded an Early Stage Capital and Retention grant from the Colorado Office of Economic Development and International Trade (OEDIT). This grant, in collaboration with UCHealth, funded a project to automatically detect when high-risk heart failure (HF) patients are not prescribed evidence-based medications, and gives healthcare providers a non-interruptive method to ensure their HF patients are taking medications proven to improve quality of life, prevent death, reduce hospitalizations, and lower healthcare costs.
Start Date
Projected End Date
Project Tags
  • FHIR
Project Point of Contact: weston.blakesleeremove@removerxrevu.com
Project Results